Lymphoproliferative disease in a cotton‐top marmoset after inoculation with infectious mononucleosis‐derived Epstein‐Barr virus

Injection of concentrated EBV derived from cells of the Kaplan line of infectious mononucleosis (IM) origin resulted in malignant lymphoproliferation in one out of three cotton‐top marmosets 6 weeks after inoculation. Two additional animals receiving the same isolate after incubation with an antibody‐containing human serum did not develop tumors. Inoculation of concentrated virus derived from the P3HR‐1 line of Burkitt origin did not lead to lymphoproliferation in five marmosets. Three of these received non‐neutralized, and two received neutralized P3HR‐1 virus. The tumor obtained with the Kaplan isolate revealed characteristics of a lymphosarcoma. It contained EBV‐specific DNA. In addition, EBV‐synthesizing lymphoblastoid lines were established from a tumorous lymph‐node, as well as from the spleen of the diseased marmoset. Virus recovered from these lines transformed lymphocytes derived from spleens of healthy marmosets. The tumor‐bearing animal developed low levels of anti‐VCA antibodies during the course of tumor growth. These data demonstrate the oncogenic potential of EBV directly derived from cells of IM origin.

[1]  A. Evans EB Virus , Infectious Mononucleosis , and Cancer : The Closing of the Web 1 , 2008 .

[2]  H. Hausen,et al.  Attempts to detect virus‐specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses , 1974, International journal of cancer.

[3]  F. Deinhardt,et al.  Transformation of nonhuman primate lymphocytes by Epstein-Barr virus. , 1974, Cancer research.

[4]  G. Klein,et al.  Epstein‐barr virus: Transformation of non‐human primate lymphocytes in vitro , 1974, International journal of cancer.

[5]  M. Epstein,et al.  Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). II. EB virus in a cell line from an animal with reticuloproliferative disease , 1973, International journal of cancer.

[6]  M. Epstein,et al.  Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal , 1973, International journal of cancer.

[7]  G. Miller,et al.  Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Hausen,et al.  EB viral genomes in epithelial nasopharyngeal carcinoma cells. , 1973, Nature: New biology.

[9]  W. Henle,et al.  Responses of gibbons to inoculation of Epstein-Barr virus. , 1972, The Journal of infectious diseases.

[10]  W. Henle,et al.  Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar) , 1972, International journal of cancer.

[11]  G. Klein,et al.  Sensitivity of Epstein‐Barr virus (EBV) producer and non‐producer human lymphoblastoid cell lines to superinfection with EB‐virus , 1972, International journal of cancer.

[12]  G. Miller,et al.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Nussenzweig,et al.  Binding of Sheep Red Blood Cells to a Large Population of Human Lymphocytes , 1971, Nature.

[14]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[15]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[16]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.

[17]  G. Klein,et al.  Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. , 1969, Clinical and experimental immunology.

[18]  R. Perper,et al.  Purification of lymphocytes and platelets by gradient centrifugation. , 1968, The Journal of laboratory and clinical medicine.

[19]  V. Diehl,et al.  Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis , 1968, Journal of virology.

[20]  W. Henle,et al.  Infectious Mononucleosis: Clinical Manifestations in Relation to EB Virus Antibodies , 1968 .

[21]  J. H. Pope,et al.  Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure. , 1967, Journal of the National Cancer Institute.

[22]  M. Konn,et al.  Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line , 1967, Journal of virology.

[23]  M. Epstein,et al.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). , 1966, Journal of the National Cancer Institute.

[24]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.

[25]  H. zur Hausen,et al.  EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. , 1975, Cold Spring Harbor symposia on quantitative biology.

[26]  Evans As Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web. , 1974 .

[27]  W. Henle,et al.  Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma. , 1970, Bibliotheca haematologica.

[28]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.